{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T03:34:17Z","timestamp":1794454457905,"version":"4.9.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82170724"],"award-info":[{"award-number":["82170724"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04477-6","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:37:17Z","timestamp":1760621837000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identifying the quantity profiles of amyloid signature proteins in different types of renal amyloidosis"],"prefix":"10.1186","volume":"26","author":[{"given":"Shuang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fude","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"issue":"10038","key":"4477_CR1","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","volume":"387","author":"AD Wechalekar","year":"2016","unstructured":"Wechalekar AD, Gillmore JD, Hawkins PN. Systemic amyloidosis. Lancet. 2016;387(10038):2641\u201354. https:\/\/doi.org\/10.1016\/S0140-6736(15)01274-X.","journal-title":"Lancet"},{"issue":"4","key":"4477_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/13506129.2024.2405948","volume":"31","author":"JN Buxbaum","year":"2024","unstructured":"Buxbaum JN, Eisenberg DS, F\u00e4ndrich M, McPhail DE, Merlini G, Saraiva MJM, et al. Amyloid nomenclature 2024: update, novel proteins, and recommendations by the International Society Of Amyloidosis (ISA) Nomenclature Committee. Amyloid. 2024;31(4):249\u201356. https:\/\/doi.org\/10.1080\/13506129.2024.2405948.","journal-title":"Amyloid"},{"key":"4477_CR3","doi-asserted-by":"publisher","first-page":"gfaf042","DOI":"10.1093\/ndt\/gfaf042","volume":"26","author":"M Allinovi","year":"2025","unstructured":"Allinovi M, Trivioli G, Gaudio C, L\u2019Imperio V, Rauf MU, et al. The evolving spectrum of kidney amyloidosis: advances in diagnosis, typing and treatment. Nephrol Dial Transpl. 2025;26:gfaf042. https:\/\/doi.org\/10.1093\/ndt\/gfaf042.","journal-title":"Nephrol Dial Transpl"},{"issue":"9","key":"4477_CR4","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.2215\/CJN.10491012","volume":"8","author":"SM Said","year":"2013","unstructured":"Said SM, Sethi S, Valeri AM, Leung N, Cornell LD, Fidler ME, et al. Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases. Clin J Am Soc Nephrol. 2013;8(9):1515\u201323. https:\/\/doi.org\/10.2215\/CJN.10491012.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"4477_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/BF02890128","volume":"48","author":"T Shirahama","year":"1985","unstructured":"Shirahama T, Skinner M, Sipe JD, Cohen AS. Widespread occurrence of AP in amyloidotic tissues. An immunohistochemical observation. Virchows Arch B Cell Pathol Incl Mol Pathol. 1985;48(3):197\u2013206. https:\/\/doi.org\/10.1007\/BF02890128.","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"issue":"3","key":"4477_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1136\/jcp.44.3.200","volume":"44","author":"RJ Fitzmaurice","year":"1991","unstructured":"Fitzmaurice RJ, Bartley C, McClure J, Ackrill P. Immunohistological characterisation of amyloid deposits in renal biopsy specimens. J Clin Pathol. 1991;44(3):200\u20134. https:\/\/doi.org\/10.1136\/jcp.44.3.200.","journal-title":"J Clin Pathol"},{"issue":"5","key":"4477_CR7","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/j.1440-1827.1998.tb03919.x","volume":"48","author":"D Cui","year":"1998","unstructured":"Cui D, Hoshii Y, Takahashi M, Kawano H, Iwata T, Ishihara T. An immunohistochemical study of amyloid P component, apolipoprotein E and ubiquitin in human and murine amyloidoses. Pathol Int. 1998;48(5):362\u20137. https:\/\/doi.org\/10.1111\/j.1440-1827.1998.tb03919.x.","journal-title":"Pathol Int"},{"issue":"7","key":"4477_CR8","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.3324\/haematol.2013.102764","volume":"99","author":"JA Vrana","year":"2014","unstructured":"Vrana JA, Theis JD, Dasari S, Mereuta OM, Dispenzieri A, Zeldenrust SR, et al. Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics. Haematologica. 2014;99(7):1239\u201347. https:\/\/doi.org\/10.3324\/haematol.2013.102764.","journal-title":"Haematologica"},{"key":"4477_CR9","doi-asserted-by":"publisher","unstructured":"Dasari S, Theis JD, Vrana JA, Rech KL, Dao LN, Howard MT, et al. Amyloid typing by mass spectrometry in clinical practice: a comprehensive review of 16,175 samples. Mayo Clin Proc. 2020;95(9):1852\u201364. https:\/\/doi.org\/10.1016\/j.mayocp.2020.06.029","DOI":"10.1016\/j.mayocp.2020.06.029"},{"issue":"3","key":"4477_CR10","first-page":"526","volume":"145","author":"G Gallo","year":"1994","unstructured":"Gallo G, Wisniewski T, Choi-Miura NH, Ghiso J, Frangione B. Potential role of apolipoprotein-E in fibrillogenesis. Am J Pathol. 1994;145(3):526\u201330.","journal-title":"Am J Pathol"},{"issue":"6","key":"4477_CR11","doi-asserted-by":"publisher","first-page":"915","DOI":"10.2215\/CJN.07030712","volume":"8","author":"S Sethi","year":"2013","unstructured":"Sethi S, Theis JD, Vrana JA, Fervenza FC, Sethi A, Qian Q, et al. Laser microdissection and proteomic analysis of amyloidosis, cryoglobulinemic GN, fibrillary GN, and immunotactoid glomerulopathy. Clin J Am Soc Nephrol. 2013;8(6):915\u201321. https:\/\/doi.org\/10.2215\/CJN.07030712.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7320","key":"4477_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nature09494","volume":"468","author":"K Bodin","year":"2010","unstructured":"Bodin K, Ellmerich S, Kahan MC, Tennent GA, Loesch A, Gilbertson JA, et al. Antibodies to human serum amyloid P component eliminate visceral amyloid deposits. Nature. 2010;468(7320):93\u20137. https:\/\/doi.org\/10.1038\/nature09494.","journal-title":"Nature"},{"issue":"12","key":"4477_CR13","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1056\/NEJMoa1504942","volume":"373","author":"DB Richards","year":"2015","unstructured":"Richards DB, Cookson LM, Berges AC, Barton SV, Lane T, Ritter JM, et al. Therapeutic clearance of amyloid by antibodies to serum amyloid P component. N Engl J Med. 2015;373(12):1106\u201314. https:\/\/doi.org\/10.1056\/NEJMoa1504942.","journal-title":"N Engl J Med"},{"issue":"422","key":"4477_CR14","doi-asserted-by":"publisher","first-page":"eaan3128","DOI":"10.1126\/scitranslmed.aan3128","volume":"10","author":"DB Richards","year":"2018","unstructured":"Richards DB, Cookson LM, Barton SV, Liefaard L, Lane T, Hutt DF, et al. Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis. Sci Transl Med. 2018;10(422):eaan3128. https:\/\/doi.org\/10.1126\/scitranslmed.aan3128.","journal-title":"Sci Transl Med"},{"issue":"2","key":"4477_CR15","first-page":"284","volume":"38","author":"MB Pepys","year":"1979","unstructured":"Pepys MB, Dyck RF, de Beer FC, Skinner M, Cohen AS. Binding of serum amyloid P-component (SAP) by amyloid fibrils. Clin Exp Immunol. 1979;38(2):284\u201393.","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"4477_CR16","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1073\/pnas.92.10.4299","volume":"92","author":"GA Tennet","year":"1995","unstructured":"Tennet GA, Lovat LB, Pepys MB. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. Proc Natl Acad Sci U S A. 1995;92(10):4299\u2013303. https:\/\/doi.org\/10.1073\/pnas.92.10.4299.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"4477_CR17","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nm0897-855","volume":"3","author":"M Botto","year":"1997","unstructured":"Botto M, Hawkins PN, Bickerstaff MC, Herbert J, Bygrave AE, McBride A, et al. Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene. Nat Med. 1997;3(8):855\u20139. https:\/\/doi.org\/10.1038\/nm0897-855.","journal-title":"Nat Med"},{"issue":"5123","key":"4477_CR18","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science. 1993;261(5123):921\u20133. https:\/\/doi.org\/10.1126\/science.8346443.","journal-title":"Science"},{"issue":"2","key":"4477_CR19","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng0694-180","volume":"7","author":"EH Corder","year":"1994","unstructured":"Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC Jr, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994;7(2):180\u20134. https:\/\/doi.org\/10.1038\/ng0694-180.","journal-title":"Nat Genet"},{"issue":"6","key":"4477_CR20","doi-asserted-by":"publisher","first-page":"G628","DOI":"10.1152\/ajpgi.00225.2011","volume":"302","author":"AB Kohan","year":"2012","unstructured":"Kohan AB, Wang F, Li X, Bradshaw S, Yang Q, Caldwell JL, et al. Apolipoprotein A-IV regulates chylomicron metabolism-mechanism and function. Am J Physiol Gastrointest Liver Physiol. 2012;302(6):G628\u201336. https:\/\/doi.org\/10.1152\/ajpgi.00225.2011.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"4477_CR21","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1093\/ndt\/gfs501","volume":"28","author":"Y Yao","year":"2013","unstructured":"Yao Y, Wang SX, Zhang YK, Qu Z, Liu G, et al. A clinicopathological analysis in a large cohort of Chinese patients with renal amyloid light-chain amyloidosis. Nephrol Dial Transpl. 2013;28(3):689\u201397. https:\/\/doi.org\/10.1093\/ndt\/gfs501.","journal-title":"Nephrol Dial Transpl"},{"issue":"2","key":"4477_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/13506129.2024.2434899","volume":"32","author":"GJ Morgan","year":"2025","unstructured":"Morgan GJ, Nau AN, Wong S, Spencer BH, Shen Y, Hua A, et al. An updated AL-base reveals ranked enrichment of Immunoglobulin light chain variable genes in AL amyloidosis. Amyloid. 2025;32(2):129\u201338. https:\/\/doi.org\/10.1080\/13506129.2024.2434899.","journal-title":"Amyloid"},{"issue":"3","key":"4477_CR23","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.kint.2023.11.023","volume":"105","author":"C Charalampous","year":"2024","unstructured":"Charalampous C, Dasari S, McPhail E, Theis JD, Vrana JA, Dispenzieri A, et al. A proteomic atlas of kidney amyloidosis provides insights into disease pathogenesis. Kidney Int. 2024;105(3):484\u201395. https:\/\/doi.org\/10.1016\/j.kint.2023.11.023.","journal-title":"Kidney Int"},{"key":"4477_CR24","doi-asserted-by":"publisher","unstructured":"Saeed SM, Fine G. Thioflavin-T for amyloid detection. Am J Clin Pathol. 1967;47:588\u201393. https:\/\/doi.org\/10.1093\/ajcp\/47.5.588.","DOI":"10.1093\/ajcp\/47.5.588"},{"issue":"24","key":"4477_CR25","doi-asserted-by":"publisher","first-page":"9758","DOI":"10.1073\/pnas.1218402110","volume":"110","author":"SI Cohen","year":"2013","unstructured":"Cohen SI, Linse S, Luheshi LM, Hellstrand E, White DA, et al. Proliferation of amyloid-\u03b242 aggregates occurs through a secondary nucleation mechanism. Proc Natl Acad Sci U S A. 2013;110(24):9758\u201363. https:\/\/doi.org\/10.1073\/pnas.1218402110.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"44","key":"4477_CR26","doi-asserted-by":"publisher","first-page":"26041","DOI":"10.1074\/jbc.270.44.26041","volume":"270","author":"S Janciauskiene","year":"1995","unstructured":"Janciauskiene S, Garc\u00eda de Frutos P, Carlemalm E, Dahlb\u00e4ck B, Eriksson S. Inhibition of Alzheimer beta-peptide fibril formation by serum amyloid P component. J Biol Chem. 1995;270(44):26041\u20134. https:\/\/doi.org\/10.1074\/jbc.270.44.26041.","journal-title":"J Biol Chem"},{"issue":"20","key":"4477_CR27","doi-asserted-by":"publisher","first-page":"6243","DOI":"10.1021\/bi9624705","volume":"36","author":"H Naiki","year":"1997","unstructured":"Naiki H, Gejyo F, Nakakuk K. Concentration-dependent inhibitory effects of apolipoprotein E on Alzheimer\u2019s \u03b2-amyloid fibril formation in vitro. Biochemistry. 1997;36(20):6243\u201350. https:\/\/doi.org\/10.1021\/bi9624705.","journal-title":"Biochemistry"},{"issue":"1","key":"4477_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13506129.2022.2120800","volume":"30","author":"Y Misumi","year":"2023","unstructured":"Misumi Y, Tabata Y, Tasaki M, Obayashi K, Yamakawa S, Nomura T, et al. Binding of serum-derived amyloid-associated proteins to amyloid fibrils. Amyloid. 2023;30(1):1\u20137. https:\/\/doi.org\/10.1080\/13506129.2022.2120800.","journal-title":"Amyloid"},{"issue":"1","key":"4477_CR29","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/s41467-019-09032-0","volume":"10","author":"L Radamaker","year":"2019","unstructured":"Radamaker L, Lin YH, Annamalai K, Huhn S, Hegenbart U, Sch\u00f6nland SO, et al. Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis. Nat Commun. 2019;10(1):1103. https:\/\/doi.org\/10.1038\/s41467-019-09032-0.","journal-title":"Nat Commun"},{"issue":"1","key":"4477_CR30","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/s41467-019-09133-w","volume":"10","author":"P Swuec","year":"2019","unstructured":"Swuec P, Lavatelli F, Tasaki M, Paissoni C, Rognoni P, Maritan M, et al. Cryo-EM structure of cardiac amyloid fibrils from an Immunoglobulin light chain AL amyloidosis patient. Nat Commun. 2019;10(1):1269. https:\/\/doi.org\/10.1038\/s41467-019-09133-w.","journal-title":"Nat Commun"},{"issue":"1","key":"4477_CR31","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41467-021-21129-z","volume":"12","author":"A Bansal","year":"2021","unstructured":"Bansal A, Schmidt M, Rennegarbe M, Haupt C, Liberta F, Stecher S, et al. AA amyloid fibrils from diseased tissue are structurally different from in vitro formed SAA fibrils. Nat Commun. 2021;12(1):1013. https:\/\/doi.org\/10.1038\/s41467-021-21129-z.","journal-title":"Nat Commun"},{"issue":"1","key":"4477_CR32","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/s41467-021-21126-2","volume":"12","author":"L Radamaker","year":"2021","unstructured":"Radamaker L, Baur J, Huhn S, Haupt C, Hegenbart U, Sch\u00f6nland S, et al. Cryo-EM reveals structural breaks in a patient-derived amyloid fibril from systemic AL amyloidosis. Nat Commun. 2021;12(1):875. https:\/\/doi.org\/10.1038\/s41467-021-21126-2.","journal-title":"Nat Commun"},{"issue":"1","key":"4477_CR33","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.1038\/s41467-024-49520-6","volume":"15","author":"S Karimi-Farsijani","year":"2024","unstructured":"Karimi-Farsijani S, Pfeiffer PB, Banerjee S, Baur J, Kuhn L, Kupfer N, et al. Light chain mutations contribute to defining the fibril morphology in systemic AL amyloidosis. Nat Commun. 2024;15(1):5121. https:\/\/doi.org\/10.1038\/s41467-024-49520-6.","journal-title":"Nat Commun"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04477-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04477-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04477-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:37:18Z","timestamp":1760621838000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04477-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4477"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04477-6","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"assertion":[{"value":"14 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adhered to the Declaration of Helsinki. Ethical approval was obtained from the Ethics Committee of Peking University First Hospital (2022\u2009\u2212\u2009448), written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"576"}}